Stay updated on Gemcitabine Cisplatin Nivolumab in Bladder Sparing Clinical Trial
Sign up to get notified when there's something new on the Gemcitabine Cisplatin Nivolumab in Bladder Sparing Clinical Trial page.

Latest updates to the Gemcitabine Cisplatin Nivolumab in Bladder Sparing Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedRevision: v3.5.0 added and Revision: v3.4.3 removed.SummaryDifference0.1%

- Check23 days agoChange DetectedAdded Revision: v3.4.3; Deleted Revision: v3.4.2. This seems to be a system update rather than a substantive change to study details.SummaryDifference0.1%

- Check52 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2; no visible edits to core study data, eligibility criteria, outcomes, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check59 days agoChange DetectedRevision: v3.4.1 is listed, replacing v3.4.0, with no substantive study content changed; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check66 days agoChange DetectedAdded a Show glossary option and updated QC-related labels to 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0'. Removed the previous items 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'.SummaryDifference0.2%

- Check81 days agoChange DetectedPage revision updated from v3.3.3 to v3.3.4.SummaryDifference0.1%

Stay in the know with updates to Gemcitabine Cisplatin Nivolumab in Bladder Sparing Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Gemcitabine Cisplatin Nivolumab in Bladder Sparing Clinical Trial page.